CLINICAL_TRIALS
trial_result
· 2021-10-22
Clinical Trial Update: A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 trial comparing two weekly doses of semaglutide in adults with type 2 diabetes has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2021-10-22